| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO
|
Kollmannsberger, C.
|
|
|
16 |
8 |
p. 1326-1333
|
article
|
| 2 |
Adjuvant chemotherapy for elderly patients (≥70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients † † Presented in part at the 40th Annual Meeting of the American Society of Clinical Oncology, poster session, June 5–8, 2004, New Orleans, US.
|
Brunello, A.
|
|
|
16 |
8 |
p. 1276-1282
|
article
|
| 3 |
A 2-month cisplatin–epirubicin–paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study
|
Frasci, G.
|
|
|
16 |
8 |
p. 1268-1275
|
article
|
| 4 |
Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology
|
Krüger, W.H.
|
|
|
16 |
8 |
p. 1381-1390
|
article
|
| 5 |
Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene
|
Menendez, J.A.
|
|
|
16 |
8 |
p. 1253-1267
|
article
|
| 6 |
Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients
|
Vanhuyse, M.
|
|
|
16 |
8 |
p. 1283-1288
|
article
|
| 7 |
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors
|
Holden, S.N.
|
|
|
16 |
8 |
p. 1391-1397
|
article
|
| 8 |
Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone
|
Park, Y.H.
|
|
|
16 |
8 |
p. 1401-1402
|
article
|
| 9 |
Cyclophosphamide-methotrexate ‘metronomic’ chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation
|
Bocci, G.
|
|
|
16 |
8 |
p. 1243-1252
|
article
|
| 10 |
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study
|
Josting, A.
|
|
|
16 |
8 |
p. 1359-1365
|
article
|
| 11 |
In this issue
|
|
|
|
16 |
8 |
p. 1215
|
article
|
| 12 |
Is cardiac troponin T serum level an accurate surrogate for acute doxorubicin-related myocardial injury?
|
Ferretti, G.
|
|
|
16 |
8 |
p. 1403-1404
|
article
|
| 13 |
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?
|
Bajetta, E.
|
|
|
16 |
8 |
p. 1374-1380
|
article
|
| 14 |
Little response to zoledronic acid in a child of juvenile myelomonocytic leukemia (JMML) harboring the PTPN11 mutation
|
Shimada, H.
|
|
|
16 |
8 |
p. 1400
|
article
|
| 15 |
Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature
|
Hennessy, B.T.
|
|
|
16 |
8 |
p. 1289-1296
|
article
|
| 16 |
Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?
|
Copie-Bergman, C.
|
|
|
16 |
8 |
p. 1232-1236
|
article
|
| 17 |
Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer
|
Negri, F.V.
|
|
|
16 |
8 |
p. 1305-1310
|
article
|
| 18 |
Myeloma bone disease: pathophysiology and management
|
Terpos, E.
|
|
|
16 |
8 |
p. 1223-1231
|
article
|
| 19 |
Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer
|
Gradishar, W.J.
|
|
|
16 |
8 |
p. 1297-1304
|
article
|
| 20 |
Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates
|
Folprecht, G.
|
|
|
16 |
8 |
p. 1311-1319
|
article
|
| 21 |
Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus
|
Mauer, A.M.
|
|
|
16 |
8 |
p. 1320-1325
|
article
|
| 22 |
Pretreatment prognostic factors and treatment outcome in elderly patients with de novo acute myeloid leukemia
|
Chen, C.-C.
|
|
|
16 |
8 |
p. 1366-1373
|
article
|
| 23 |
Reply to the Letter to the Editor on “Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients”, by I. Cohen Ann Oncol 2005; 16: 1399
|
Paridaens, R.
|
|
|
16 |
8 |
p. 1402-1403
|
article
|
| 24 |
Response to “Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients”, by L. Morales et al. (Ann Oncol 2005; 16: 70–74)
|
Cohen, I.
|
|
|
16 |
8 |
p. 1402
|
article
|
| 25 |
Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group
|
Campone, M.
|
|
|
16 |
8 |
p. 1343-1351
|
article
|
| 26 |
Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease
|
Barranger, E.
|
|
|
16 |
8 |
p. 1237-1242
|
article
|
| 27 |
Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy
|
Ghesquieres, H.
|
|
|
16 |
8 |
p. 1399
|
article
|
| 28 |
Table of Contents
|
|
|
|
16 |
8 |
p. i-ii
|
article
|
| 29 |
The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer
|
Zhang, X.-T.
|
|
|
16 |
8 |
p. 1334-1342
|
article
|
| 30 |
Treatment of advanced breast cancer: the good, the bad and the ugly
|
Colleoni, M.
|
|
|
16 |
8 |
p. 1219-1221
|
article
|
| 31 |
Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas
|
Monfardini, S.
|
|
|
16 |
8 |
p. 1352-1358
|
article
|
| 32 |
What is the impact of sentinel node biopsy in the management of cancer?
|
Lejeune, F.J.
|
|
|
16 |
8 |
p. 1217-1218
|
article
|
Journal description